ARK Investment Management LLC and CEO Catherine D. Wood disclose an 11.43% stake in Beam Therapeutics, highlighting confidence in the biotechnology sector.
| Name | Beam Therapeutics Inc. |
|---|---|
| CIK | 0001745999 |
| Tickers | BEAM |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 857-327-8775 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
ARK Investment Management LLC and CEO Catherine D. Wood disclose an 11.43% stake in Beam Therapeutics, highlighting confidence in the biotechnology sector.
Beam Therapeutics shares its Q3 financial results and strategic updates, reflecting its growth in the biological products sector.
Beam Therapeutics Inc. shares key operational and financial updates in its latest SEC filing, highlighting its commitment to transparency and innovation.
515 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-126822 | 005-91369 | 261550635 | 34 | 13679 | |||
| 2026-11-03 | 10-Q | 10-Q | 0001193125-26-444455 | 001-39208 | 261514509 | 34 | 12811111 | 1 | 1 | |
| 2026-11-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-444454 | 001-39208 | 261514497 | 34 | 439153 | 1 | 1 |
| 2026-10-16 | 4 | 4 | 0001193125-26-424421 | 15097 | ||||||
| 2026-10-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010282 | 001-39208 | 261466199 | 33 | 5495 | |||
| 2026-10-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010253 | 001-39208 | 261463330 | 33 | 4807 | |||
| 2026-10-02 | 4 | 4 | 0001193125-26-412236 | 5066 | ||||||
| 2026-09-25 | 4 | 4 | 0001193125-26-402814 | 5720 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-096939 | 005-91369 | 261280196 | 34 | 13534 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000908834-26-000397 | 005-91369 | 261274876 | 34 | 49379 | |||
| 2026-08-04 | 10-Q | 10-Q | 0001193125-26-331541 | 001-39208 | 261235433 | 34 | 12347478 | 1 | 1 | |
| 2026-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-331522 | 001-39208 | 261235423 | 34 | 416906 | 1 | 1 |
| 2026-07-29 | 4 | 4 | 0001193125-26-323640 | 5264 | ||||||
| 2026-07-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007314 | 001-39208 | 261205713 | 33 | 5993 | |||
| 2026-07-02 | 4 | 4 | 0001193125-26-294478 | 5056 | ||||||
| 2026-07-01 | 4 | 4 | 0001193125-26-292526 | 22777 | ||||||
| 2026-06-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006639 | 001-39208 | 261140753 | 33 | 6871 | |||
| 2026-06-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006578 | 001-39208 | 261135907 | 33 | 6871 | |||
| 2026-06-29 | 4 | 4 | 0001193125-26-288078 | 10155 | ||||||
| 2026-06-22 | 4 | 4 | 0001193125-26-277509 | 10231 | ||||||
| 2026-06-08 | 8-K | 8-K | 5.07 | 0001193125-26-261693 | 001-39208 | 261072585 | 34 | 202824 | 1 | 1 |
| 2026-06-05 | 4 | 4 | 0001193125-26-259529 | 5417 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259526 | 5456 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259524 | 5410 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259536 | 5452 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259534 | 5437 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259519 | 5463 | ||||||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-210338 | 001-39208 | 26950862 | 34 | 13205192 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-210299 | 001-39208 | 26950815 | 34 | 358756 | 1 | 1 |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000189 | 005-91369 | 26917513 | 34 | 7323 | |||
| 2026-04-17 | ARS | ARS | 0001193125-26-161561 | 001-39208 | 26871721 | 34 | 1550703 | |||
| 2026-04-17 | DEFA14A | DEFA14A | 0001193125-26-161541 | 001-39208 | 26871622 | 34 | 1332390 | |||
| 2026-04-17 | DEF 14A | DEF 14A | 0001193125-26-161512 | 001-39208 | 26871517 | 34 | 4623957 | 1 | 1 | |
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003430 | 001-39208 | 26861127 | 33 | 4648 | |||
| 2026-04-06 | 4 | 4 | 0001193125-26-144086 | 6049 | ||||||
| 2026-04-06 | 4 | 4 | 0001193125-26-144080 | 5382 | ||||||
| 2026-04-06 | 4 | 4 | 0001193125-26-144068 | 5121 | ||||||
| 2026-04-06 | 4 | 4 | 0001193125-26-144067 | 5091 | ||||||
| 2026-04-06 | 4 | 4 | 0001193125-26-144054 | 5105 | ||||||
| 2026-04-02 | 4 | 4 | 0001193125-26-140586 | 5059 | ||||||
| 2026-04-02 | 4 | 4 | 0001193125-26-140553 | 5087 | ||||||
| 2026-04-02 | 4 | 4 | 0001193125-26-140515 | 5068 | ||||||
| 2026-04-02 | 4 | 4 | 0001193125-26-140513 | 5058 | ||||||
| 2026-04-02 | 4 | 4 | 0001193125-26-140508 | 5072 | ||||||
| 2026-04-01 | 4 | 4 | 0001193125-26-138348 | 17074 | ||||||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-134721 | 001-39208 | 26822610 | 33 | 6238 | |||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-134691 | 001-39208 | 26822421 | 33 | 5037 | |||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-134661 | 001-39208 | 26822270 | 33 | 4394 | |||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-134643 | 001-39208 | 26822199 | 33 | 5676 | |||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003089 | 001-39208 | 26822130 | 33 | 6870 | |||
| 2026-03-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003060 | 001-39208 | 26812940 | 33 | 6182 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000785 | 005-91369 | 26798347 | 34 | 7088 | |||
| 2026-03-05 | 8-K | 8-K | 1.02 | 0001193125-26-093914 | 001-39208 | 26726088 | 34 | 145878 | 1 | 1 |
| 2026-02-26 | 4 | 4 | 0001193125-26-076544 | 8770 | ||||||
| 2026-02-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001698 | 001-39208 | 26671797 | 33 | 4748 | |||
| 2026-02-24 | S-8 | S-8 | 0001193125-26-065214 | 333-293671 | 26667516 | 33 | 371389 | 1 | 1 | |
| 2026-02-24 | 10-K | 10-K | 0001193125-26-065194 | 001-39208 | 26667451 | 34 | 18624514 | 1 | 1 | |
| 2026-02-24 | 8-K | 8-K | 1.01,2.02,2.03,9.01 | 0001193125-26-065191 | 001-39208 | 26667437 | 34 | 464451 | 1 | 1 |
| 2026-02-12 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-048684 | 001-39208 | 26626127 | 34 | 230197 | 1 | 1 |
| 2026-02-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-26-000023 | 005-91369 | 26609491 | 34 | 7932 | |||
| 2026-02-05 | 8-K | 8-K | 5.02 | 0001193125-26-039365 | 001-39208 | 26602870 | 34 | 140433 | 1 | 1 |
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-26-000048 | 005-91369 | 26602484 | 34 | 65230 | |||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000356 | 005-91369 | 26601811 | 34 | 11496 | |||
| 2026-02-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-009583 | 005-91369 | 26590922 | 34 | 12740 | |||
| 2026-02-02 | 4 | 4 | 0001193125-26-033605 | 5324 | ||||||
| 2026-02-02 | 4 | 4 | 0001193125-26-033606 | 5290 | ||||||
| 2026-02-02 | 4 | 4 | 0001193125-26-033603 | 5294 | ||||||
| 2026-02-02 | 4 | 4 | 0001193125-26-033601 | 5295 | ||||||
| 2026-02-02 | 4 | 4 | 0001193125-26-033600 | 24501 | ||||||
| 2026-02-02 | 4 | 4 | 0001193125-26-033598 | 5303 | ||||||
| 2026-01-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000761 | 001-39208 | 26583315 | 33 | 5494 | |||
| 2026-01-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000741 | 001-39208 | 26577834 | 33 | 4806 | |||
| 2026-01-26 | 4 | 4 | 0001193125-26-022563 | 5135 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-022557 | 4611 | ||||||
| 2026-01-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000626 | 001-39208 | 26551564 | 33 | 7296 | |||
| 2026-01-21 | 4 | 4 | 0001193125-26-017942 | 4622 | ||||||
| 2026-01-20 | 4 | 4 | 0001193125-26-016552 | 8886 | ||||||
| 2026-01-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000494 | 001-39208 | 26537216 | 33 | 8371 | |||
| 2026-01-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-009722 | 001-39208 | 26524617 | 34 | 12030432 | 1 | 1 |
| 2026-01-05 | 4 | 4 | 0001193125-26-002448 | 4918 | ||||||
| 2026-01-05 | 4 | 4 | 0001193125-26-002427 | 4917 | ||||||
| 2026-01-05 | 4 | 4 | 0001193125-26-002422 | 4930 | ||||||
| 2025-12-11 | 8-K | 8-K | 2.01 | 0001193125-25-316043 | 001-39208 | 251565404 | 34 | 145368 | 1 | 1 |
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002693 | 005-91369 | 251452570 | 34 | 11498 | |||
| 2025-11-04 | 10-Q | 10-Q | 0001193125-25-263542 | 001-39208 | 251446429 | 34 | 12105028 | 1 | 1 | |
| 2025-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-263536 | 001-39208 | 251446414 | 34 | 415652 | 1 | 1 |
| 2025-10-29 | 4 | 4 | 0001193125-25-255853 | 7760 | ||||||
| 2025-10-08 | 4 | 4 | 0001193125-25-234461 | 7920 | ||||||
| 2025-10-03 | 4 | 4 | 0001193125-25-230195 | 4952 | ||||||
| 2025-10-03 | 4 | 4 | 0001193125-25-230148 | 4899 | ||||||
| 2025-10-03 | 4 | 4 | 0001193125-25-230084 | 15350 | ||||||
| 2025-10-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007703 | 001-39208 | 251369490 | 33 | 5495 | |||
| 2025-10-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007616 | 001-39208 | 251364769 | 33 | 4807 | |||
| 2025-08-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-075081 | 005-91369 | 251192515 | 34 | 13663 | |||
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-001955 | 005-91369 | 251188260 | 34 | 11112 | |||
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-102393 | 001-39208 | 251182780 | 34 | 11513126 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-102389 | 001-39208 | 251182762 | 34 | 420854 | 1 | 1 |
| 2025-08-01 | 4 | 4 | 0000950170-25-101143 | 7765 | ||||||
| 2025-07-03 | 4 | 4 | 0000950170-25-094002 | 6719 | ||||||
| 2025-07-03 | 8-K | 8-K | 3.02 | 0000950170-25-093906 | 001-39208 | 251105923 | 34 | 142501 | 1 | 1 |
| 2025-06-06 | 4 | 4 | 0000950170-25-083056 | 5319 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083055 | 5315 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083054 | 5280 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083051 | 5334 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083053 | 5273 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083050 | 5325 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083052 | 5300 | ||||||
| 2025-06-06 | 8-K | 8-K | 5.07 | 0000950170-25-083043 | 001-39208 | 251030528 | 34 | 187898 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001072613-25-000405 | 005-91369 | 25955183 | 34 | 33493 | |||
| 2025-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-25-000171 | 005-91369 | 25939637 | 34 | 47657 | |||
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-063966 | 001-39208 | 25915243 | 34 | 10507319 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063955 | 001-39208 | 25915194 | 34 | 356726 | 1 | 1 |
| 2025-04-18 | ARS | ARS | 0000950170-25-055863 | 001-39208 | 25850514 | 34 | 2103215 | |||
| 2025-04-18 | DEFA14A | DEFA14A | 0000950170-25-055857 | 001-39208 | 25850472 | 34 | 1322953 | |||
| 2025-04-18 | DEF 14A | DEF 14A | 0000950170-25-055853 | 001-39208 | 25850427 | 34 | 6094419 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000564 | 005-91369 | 25844557 | 34 | 10994 | |||
| 2025-04-10 | 3 | 3 | 0000950170-25-052693 | 6975 | ||||||
| 2025-04-03 | 4 | 4 | 0000950170-25-050859 | 5442 | ||||||
| 2025-04-03 | 4 | 4 | 0000950170-25-050857 | 6386 | ||||||
| 2025-04-03 | 4 | 4 | 0000950170-25-050856 | 5461 | ||||||
| 2025-04-03 | 4 | 4 | 0000950170-25-050855 | 5478 | ||||||
| 2025-04-03 | 4 | 4 | 0000950170-25-050852 | 7501 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-049769 | 4922 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-049765 | 4927 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-049763 | 4935 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-049761 | 4950 | ||||||
| 2025-04-02 | 4 | 4 | 0000950170-25-049759 | 5635 | ||||||
| 2025-04-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-002326 | 001-39208 | 25804477 | 33 | 5406 | |||
| 2025-04-02 | 4/A | 4/A | 0000950170-25-049297 | 8638 | ||||||
| 2025-04-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-001019 | 005-91369 | 25802716 | 34 | 11359 | |||
| 2025-03-31 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-047961 | 001-39208 | 25795851 | 33 | 4396 | |||
| 2025-03-31 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-047960 | 001-39208 | 25795849 | 33 | 5669 | |||
| 2025-03-31 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-047959 | 001-39208 | 25795847 | 33 | 5632 | |||
| 2025-03-31 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-047958 | 001-39208 | 25795845 | 33 | 4424 | |||
| 2025-03-10 | 424B5 | 424B5 | 0001193125-25-051106 | 333-277427 | 25724941 | 33 | 714608 | 1 | 1 | |
| 2025-03-10 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-051072 | 001-39208 | 25724654 | 34 | 654550 | 1 | 1 |
| 2025-03-10 | FWP | FWP | 0001193125-25-050346 | 333-277427 | 25722038 | 34 | 74680 | |||
| 2025-03-10 | 424B5 | 424B5 | 0001193125-25-050343 | 333-277427 | 25722029 | 33 | 533672 | |||
| 2025-03-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-050334 | 001-39208 | 25722011 | 34 | 202637 | 1 | 1 |
| 2025-02-25 | S-8 | S-8 | 0000950170-25-026086 | 333-285182 | 25659458 | 33 | 714804 | 1 | 1 | |
| 2025-02-25 | 10-K | 10-K | 0000950170-25-026076 | 001-39208 | 25659408 | 34 | 19479546 | 1 | 1 | |
| 2025-02-25 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-026070 | 001-39208 | 25659395 | 34 | 426443 | 1 | 1 |
| 2025-02-20 | 4 | 4 | 0000950170-25-024149 | 4626 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023166 | 11922 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001072613-25-000167 | 005-91369 | 25630379 | 34 | 35389 | |||
| 2025-02-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000859 | 001-39208 | 25628457 | 33 | 5435 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000727 | 005-91369 | 25612332 | 34 | 11370 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000908834-25-000047 | 005-91369 | 25594983 | 34 | 56910 | |||
| 2025-02-03 | 4 | 4 | 0000950170-25-012307 | 5284 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012306 | 5315 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012305 | 5307 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012304 | 9530 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012303 | 5313 | ||||||
| 2025-01-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000495 | 001-39208 | 25573876 | 33 | 4812 | |||
| 2025-01-13 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-25-004558 | 001-39208 | 25524766 | 34 | 17833239 | 1 | 1 |
| 2025-01-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-002732 | 005-91369 | 25524552 | 34 | 7044 | |||
| 2025-01-06 | 4 | 4 | 0000950170-25-002358 | 5397 | ||||||
| 2025-01-06 | 4 | 4 | 0000950170-25-002355 | 5418 | ||||||
| 2025-01-02 | 4 | 4 | 0000950170-25-000624 | 7238 | ||||||
| 2024-12-30 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-141235 | 001-39208 | 241590890 | 33 | 5056 | |||
| 2024-12-30 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-141233 | 001-39208 | 241590884 | 33 | 5050 | |||
| 2024-12-19 | 4 | 4 | 0000950170-24-138447 | 6724 | ||||||
| 2024-12-19 | 3 | 3 | 0000950170-24-138427 | 16666 | ||||||
| 2024-12-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-272860 | 001-39208 | 241533830 | 34 | 231738 | 1 | 1 |
| 2024-12-06 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-271965 | 001-39208 | 241530527 | 34 | 174301 | 1 | 1 |
| 2024-12-04 | 4 | 4 | 0000950170-24-133080 | 5305 | ||||||
| 2024-12-04 | 3 | 3 | 0000950170-24-133078 | 16122 | ||||||
| 2024-12-04 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-270314 | 001-39208 | 241524796 | 34 | 163026 | 1 | 1 |
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002690 | 005-91369 | 241444467 | 34 | 7907 | |||
| 2024-11-08 | 4 | 4 | 0000950170-24-124085 | 5086 | ||||||
| 2024-11-08 | SC 13G/A | us07373v1052_110824.txt | 0002012383-24-003439 | 005-91369 | 241439525 | 34 | 13971 | |||
| 2024-11-07 | SC 13G/A | beam_13ga.htm | 0000908834-24-000290 | 005-91369 | 241433632 | 34 | 482130 | |||
| 2024-11-05 | 10-Q | 10-Q | 0000950170-24-121104 | 001-39208 | 241425936 | 34 | 9805544 | 1 | 1 | |
| 2024-11-05 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-121099 | 001-39208 | 241425911 | 34 | 216457 | 1 | 1 |
| 2024-11-05 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-121088 | 001-39208 | 241425872 | 34 | 15792283 | 1 | 1 |
| 2024-11-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-121069 | 001-39208 | 241425595 | 34 | 334869 | 1 | 1 |
| 2024-10-21 | SC 13G/A | us07373v1052_102124.txt | 0002012383-24-000930 | 005-91369 | 241383529 | 34 | 13959 | |||
| 2024-10-17 | SC 13G/A | Beam_Therapeutics_Inc.htm | 0000093751-24-000811 | 005-91369 | 241376580 | 34 | 55963 | |||
| 2024-10-16 | 4 | 4 | 0000950170-24-115031 | 15885 | ||||||
| 2024-10-15 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000929 | 001-39208 | 241370691 | 33 | 7382 | |||
| 2024-10-07 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001399 | 001-39208 | 241358433 | 33 | 4207 | |||
| 2024-10-02 | 4 | 4 | 0000950170-24-111739 | 5400 | ||||||
| 2024-10-02 | 4 | 4 | 0000950170-24-111737 | 7301 | ||||||
| 2024-10-02 | 4 | 4 | 0000950170-24-111732 | 6053 | ||||||
| 2024-09-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007469 | 001-39208 | 241340116 | 33 | 4819 | |||
| 2024-09-03 | 4 | 4 | 0000950170-24-102823 | 5329 | ||||||
| 2024-08-19 | 3 | 3 | 0000950170-24-098531 | 24846 | ||||||
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091242 | 001-39208 | 241177270 | 34 | 9705060 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-091201 | 001-39208 | 241177056 | 34 | 331595 | 1 | 1 |
| 2024-07-15 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-178824 | 001-39208 | 241115850 | 34 | 167317 | 1 | 1 |
| 2024-07-03 | 4 | 4 | 0000950170-24-081492 | 6775 | ||||||
| 2024-06-28 | 4 | 4 | 0000950170-24-079065 | 5828 | ||||||
| 2024-06-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-005051 | 001-39208 | 241079434 | 33 | 6196 | |||
| 2024-06-10 | 8-K | 8-K | 5.07 | 0000950170-24-071345 | 001-39208 | 241033163 | 34 | 172413 | 1 | 1 |
| 2024-06-07 | 4 | 4 | 0000950170-24-070793 | 5287 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070790 | 5279 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070788 | 5399 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070783 | 5332 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070768 | 5325 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070766 | 5321 | ||||||
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-053939 | 001-39208 | 24919601 | 34 | 8756614 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-053928 | 001-39208 | 24919577 | 34 | 277510 | 1 | 1 |
| 2024-04-29 | 4 | 4 | 0000950170-24-049854 | 7273 | ||||||
| 2024-04-19 | ARS | ARS | 0000950170-24-046028 | 001-39208 | 24858097 | 34 | 2315334 | |||
| 2024-04-19 | DEFA14A | DEFA14A | 0000950170-24-046022 | 001-39208 | 24858033 | 34 | 1292823 | |||
| 2024-04-19 | DEF 14A | DEF 14A | 0000950170-24-046017 | 001-39208 | 24857936 | 34 | 4615381 | 1 | 1 | |
| 2024-04-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-042028 | 001-39208 | 24824526 | 33 | 5678 | |||
| 2024-04-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-042027 | 001-39208 | 24824525 | 33 | 4424 | |||
| 2024-04-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-042026 | 001-39208 | 24824522 | 33 | 4430 | |||
| 2024-04-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-042025 | 001-39208 | 24824520 | 33 | 5030 | |||
| 2024-04-04 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-042024 | 001-39208 | 24824517 | 33 | 5004 | |||
| 2024-04-03 | 4 | 4 | 0000950170-24-041441 | 7486 | ||||||
| 2024-04-03 | 4 | 4 | 0000950170-24-041438 | 5437 | ||||||
| 2024-04-03 | 4 | 4 | 0000950170-24-041437 | 5459 | ||||||
| 2024-04-03 | 4 | 4 | 0000950170-24-041432 | 11127 | ||||||
| 2024-04-03 | 4 | 4 | 0000950170-24-041426 | 10423 | ||||||
| 2024-04-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002884 | 001-39208 | 24814579 | 33 | 5413 | |||
| 2024-04-02 | 4 | 4 | 0000950170-24-040154 | 5227 | ||||||
| 2024-04-02 | 4 | 4 | 0000950170-24-040152 | 5210 | ||||||
| 2024-04-02 | 4 | 4 | 0000950170-24-040151 | 4945 | ||||||
| 2024-04-02 | 4 | 4 | 0000950170-24-040150 | 4932 | ||||||
| 2024-04-01 | 4 | 4 | 0000950170-24-039319 | 7940 | ||||||
| 2024-03-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-002764 | 001-39208 | 24801045 | 33 | 5507 | |||
| 2024-02-28 | S-3ASR | S-3ASR | 0001193125-24-048201 | 333-277427 | 24689032 | 33 | 1559103 | |||
| 2024-02-27 | S-8 | S-8 | 0000950170-24-020628 | 333-277382 | 24682013 | 33 | 320287 | |||
| 2024-02-27 | 10-K | 10-K | 0000950170-24-020622 | 001-39208 | 24681972 | 34 | 17475784 | 1 | 1 | |
| 2024-02-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-020608 | 001-39208 | 24681861 | 34 | 343816 | 1 | 1 |
| 2024-02-15 | 4 | FORM 4 SUBMISSION | 0001209191-24-003394 | 12474 | ||||||
| 2024-02-14 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#2) | 0001072613-24-000251 | 005-91369 | 24636714 | 34 | 277435 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020412 | 005-91369 | 24627643 | 34 | 13032 | |||
| 2024-02-12 | SC 13G/A | beam_13ga.htm | 0000908834-24-000051 | 005-91369 | 24619589 | 34 | 433172 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-000973 | 005-91369 | 24611349 | 34 | 7910 | |||
| 2024-02-06 | SC 13G/A | SC 13G/A | 0001193125-24-024797 | 005-91369 | 24598086 | 34 | 42983 | |||
| 2024-02-02 | 4 | 4 | 0000950170-24-010480 | 5329 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010479 | 5305 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010478 | 5312 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010477 | 8372 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010474 | 5319 | ||||||
| 2024-01-31 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000541 | 001-39208 | 24583561 | 33 | 4819 | |||
| 2024-01-29 | SC 13G/A | SC 13G/A | 0001104659-24-007680 | 005-91369 | 24573531 | 34 | 52877 | |||
| 2024-01-25 | SC 13G/A | us07373v1052_012524.txt | 0001086364-24-003822 | 005-91369 | 24563025 | 34 | 13610 | |||
| 2024-01-24 | SC 13G | Beam_Therap_Inc.txt | 0000093751-24-000121 | 005-91369 | 24554364 | 34 | 8479 | |||
| 2024-01-08 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-24-002673 | 001-39208 | 24518250 | 34 | 12875704 | 1 | 1 |
| 2024-01-05 | 4 | 4 | 0000950170-24-002480 | 4905 | ||||||
| 2023-12-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-059756 | 7450 | ||||||
| 2023-12-14 | 4 | 4 | 0000950170-23-070395 | 5207 | ||||||
| 2023-12-14 | 3 | 3 | 0000950170-23-070390 | 14637 | ||||||
| 2023-12-14 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-295457 | 001-39208 | 231487117 | 34 | 162194 | 1 | 1 |
| 2023-11-22 | 4 | 4 | 0000950170-23-065868 | 13242 | ||||||
| 2023-11-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-005224 | 001-39208 | 231423032 | 33 | 5353 | |||
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-060683 | 001-39208 | 231385959 | 34 | 11237987 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-060660 | 001-39208 | 231385897 | 34 | 419017 | 1 | 1 |
| 2023-11-01 | 4 | 4 | 0000950170-23-057499 | 4512 | ||||||
| 2023-10-31 | 8-K | 8-K | 2.01,3.02,8.01,9.01 | 0000950170-23-056542 | 001-39208 | 231362217 | 34 | 206266 | 1 | 1 |
| 2023-10-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004631 | 001-39208 | 231360895 | 33 | 5233 | |||
| 2023-10-24 | 4 | 4 | 0000950170-23-054850 | 6654 | ||||||
| 2023-10-19 | 8-K | 8-K | 2.05,7.01,8.01,9.01 | 0001193125-23-258963 | 001-39208 | 231333446 | 34 | 3452880 | 1 | 1 |
| 2023-10-12 | UPLOAD | filename1.pdf | 0000000000-23-011145 | 39661 | ||||||
| 2023-10-04 | 4 | 4 | 0000950170-23-051915 | 4823 | ||||||
| 2023-09-22 | SC 13G | beam13g.htm | 0000908834-23-000114 | 005-91369 | 231271451 | 34 | 608928 | |||
| 2023-09-20 | CORRESP | filename1.htm | 0001193125-23-238645 | 114368 | ||||||
| 2023-08-22 | UPLOAD | filename1.pdf | 0000000000-23-009179 | 48244 | ||||||
| 2023-08-09 | CORRESP | filename1.htm | 0001193125-23-207411 | 61303 | ||||||
| 2023-08-09 | 4 | 4 | 0000950170-23-040574 | 4838 | ||||||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039364 | 001-39208 | 231149341 | 34 | 11892459 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039356 | 001-39208 | 231149285 | 34 | 427707 | 1 | 1 |
| 2023-07-25 | 4 | 4 | 0000950170-23-034518 | 17755 | ||||||
| 2023-07-21 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000350 | 001-39208 | 231103456 | 33 | 5973 | |||
| 2023-07-20 | UPLOAD | filename1.pdf | 0000000000-23-007716 | 45113 | ||||||
| 2023-06-08 | 4 | 4 | 0000950170-23-027060 | 9017 | ||||||
| 2023-06-08 | 4 | 4 | 0000950170-23-027049 | 5229 | ||||||
| 2023-06-08 | 4 | 4 | 0000950170-23-027046 | 5222 | ||||||
| 2023-06-08 | 4 | 4 | 0000950170-23-027045 | 5218 | ||||||
| 2023-06-08 | 4 | 4 | 0000950170-23-027040 | 5237 | ||||||
| 2023-06-08 | 4 | 4 | 0000950170-23-027037 | 5178 | ||||||
| 2023-06-08 | 8-K | 8-K | 5.07 | 0000950170-23-027026 | 001-39208 | 231002363 | 34 | 213962 | 1 | 1 |
| 2023-05-10 | 424B5 | 424B5 | 0001193125-23-140856 | 333-254946 | 23907612 | 33 | 343900 | |||
| 2023-05-10 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-140832 | 001-39208 | 23907416 | 34 | 200850 | 1 | 1 |
| 2023-05-10 | 10-Q | 10-Q | 0000950170-23-020090 | 001-39208 | 23904349 | 34 | 10944013 | 1 | 1 | |
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020063 | 001-39208 | 23904275 | 34 | 363838 | 1 | 1 |
| 2023-04-21 | ARS | ARS | 0000950170-23-013848 | 001-39208 | 23836542 | 34 | 1361068 | |||
| 2023-04-21 | DEFA14A | DEFA14A | 0000950170-23-013842 | 001-39208 | 23836477 | 34 | 1325429 | |||
| 2023-04-21 | DEF 14A | DEF 14A | 0000950170-23-013837 | 001-39208 | 23836394 | 34 | 4787592 | 1 | 1 | |
| 2023-04-19 | 4/A | 4/A | 0000950170-23-013483 | 5725 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-010819 | 7790 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-010818 | 6853 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-010817 | 6826 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-010816 | 9122 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-010815 | 7090 | ||||||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-23-010140 | 12962 | ||||||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-23-010138 | 7582 | ||||||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-23-010137 | 14139 | ||||||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-23-010134 | 5090 | ||||||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-23-010132 | 7576 | ||||||
| 2023-03-27 | 3 | FORM 3 SUBMISSION | 0000899243-23-009751 | 13171 | ||||||
| 2023-03-27 | 3 | FORM 3 SUBMISSION | 0000899243-23-009750 | 17641 | ||||||
| 2023-03-17 | SC 13G | SC 13G | 0001193125-23-073117 | 005-91369 | 23740611 | 34 | 43198 | |||
| 2023-02-28 | S-8 | S-8 | 0000950170-23-004870 | 333-270079 | 23678444 | 33 | 270161 | |||
| 2023-02-28 | 10-K | 10-K | 0000950170-23-004866 | 001-39208 | 23678381 | 34 | 23066884 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-004858 | 001-39208 | 23678309 | 34 | 449540 | 1 | 1 |
| 2023-02-14 | SC 13G/A | 13ga1_beam.htm | 0001175707-23-000059 | 005-91369 | 23622837 | 34 | 628462 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001104659-23-018201 | 005-91369 | 23609624 | 34 | 40557 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001193125-23-031112 | 005-91369 | 23608457 | 34 | 79815 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015434 | 005-91369 | 23602539 | 34 | 12951 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001344 | 005-91369 | 23601201 | 34 | 7769 | |||
| 2023-02-02 | SC 13G/A | us07373v1052_020223.txt | 0001306550-23-006547 | 005-91369 | 23580869 | 34 | 13402 | |||
| 2023-01-30 | 4 | FORM 4 SUBMISSION | 0000899243-23-002957 | 15235 | ||||||
| 2023-01-25 | 4 | FORM 4 SUBMISSION | 0000899243-23-002666 | 15234 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0000899243-23-002260 | 9684 | ||||||
| 2023-01-09 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-23-004131 | 001-39208 | 23516534 | 34 | 13643690 | 1 | 1 |
| 2023-01-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-000973 | 22518 | ||||||
| 2023-01-03 | 4 | FORM 4 SUBMISSION | 0000899243-23-000237 | 7546 | ||||||
| 2022-12-20 | 4/A | FORM 4/A SUBMISSION | 0000899243-22-039103 | 6146 | ||||||
| 2022-12-14 | 4 | FORM 4 SUBMISSION | 0000899243-22-038538 | 17297 | ||||||
| 2022-11-07 | 10-Q | 10-Q | 0000950170-22-022322 | 001-39208 | 221363732 | 34 | 14010047 | 1 | 1 | |
| 2022-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-022313 | 001-39208 | 221363672 | 34 | 476260 | 1 | 1 |
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-034759 | 18411 | ||||||
| 2022-09-08 | 4 | PRIMARY DOCUMENT | 0000315066-22-001715 | 11276 | ||||||
| 2022-09-07 | 8-K | 8-K | 8.01 | 0000950170-22-018147 | 001-39208 | 221229878 | 34 | 167903 | 1 | 1 |
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-030277 | 5321 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-030278 | 5354 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-030271 | 5289 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-030272 | 5347 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-030269 | 5340 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-030270 | 5335 | ||||||
| 2022-08-30 | 8-K | 8-K | 8.01 | 0000950170-22-017868 | 001-39208 | 221212881 | 34 | 165250 | 1 | 1 |
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-015755 | 001-39208 | 221146415 | 34 | 12755222 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-015736 | 001-39208 | 221146319 | 34 | 417257 | 1 | 1 |
| 2022-08-08 | 4 | PRIMARY DOCUMENT | 0000315066-22-001678 | 20030 | ||||||
| 2022-08-01 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-013559 | 001-39208 | 221122697 | 34 | 201954 | 1 | 1 |
| 2022-07-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-027077 | 19973 | ||||||
| 2022-07-14 | SC 13G | INITIAL 13G | 0000908834-22-000110 | 005-91369 | 221083028 | 34 | 430804 | |||
| 2022-06-10 | 8-K | 8-K | 5.07 | 0000950170-22-011501 | 001-39208 | 221009653 | 34 | 234847 | 1 | 1 |
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008238 | 001-39208 | 22903255 | 34 | 11449891 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008231 | 001-39208 | 22903201 | 34 | 353479 | 1 | 1 |
| 2022-05-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-016164 | 30035 | ||||||
| 2022-04-22 | DEFA14A | DEFA14A | 0000950170-22-006017 | 001-39208 | 22845937 | 34 | 300932 | |||
| 2022-04-22 | DEF 14A | DEF 14A | 0000950170-22-006016 | 001-39208 | 22845891 | 34 | 1670824 | |||
| 2022-04-14 | 4 | PRIMARY DOCUMENT | 0000315066-22-001561 | 24065 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-013489 | 6852 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-013487 | 7722 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-013485 | 7005 | ||||||
| 2022-02-28 | S-8 | S-8 | 0001193125-22-055894 | 333-263067 | 22684055 | 33 | 85639 | |||
| 2022-02-28 | 10-K | 10-K | 0000950170-22-002166 | 001-39208 | 22683923 | 34 | 19130584 | 1 | 1 | |
| 2022-02-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-002162 | 001-39208 | 22683873 | 34 | 409957 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-023120 | 005-91369 | 22634475 | 34 | 74720 | |||
| 2022-02-14 | SC 13G/A | BEAM THERAPEUTICS INC. | 0000902664-22-001711 | 005-91369 | 22631310 | 34 | 55674 | |||
| 2022-02-14 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#1) | 0001072613-22-000149 | 005-91369 | 22627831 | 34 | 270690 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-039200 | 005-91369 | 22624945 | 34 | 98016 | |||
| 2022-02-09 | SC 13G | SCHEDULE 13G | 0001104659-22-016611 | 005-91369 | 22606539 | 34 | 12916 | |||
| 2022-02-09 | SC 13G/A | SC 13G/A | 0001104659-22-016108 | 005-91369 | 22605768 | 34 | 40355 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-000842 | 005-91369 | 22604158 | 34 | 7633 | |||
| 2022-02-04 | SC 13G | us07373v1052_020422.txt | 0000834237-22-007299 | 005-91369 | 22593565 | 34 | 13364 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004198 | 5435 | ||||||
| 2022-02-02 | 4/A | FORM 4/A SUBMISSION | 0000899243-22-004197 | 36290 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004196 | 5726 | ||||||
| 2022-01-24 | 3 | PRIMARY DOCUMENT | 0000315066-22-000058 | 8609 | ||||||
| 2022-01-24 | SC 13G/A | filing.txt | 0000315066-22-000057 | 005-91369 | 22547619 | 34 | 8199 | |||
| 2022-01-10 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-22-000163 | 001-39208 | 22519603 | 34 | 2466974 | 1 | 1 |
| 2021-12-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-050117 | 7102 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0000899243-21-049634 | 12815 | ||||||
| 2021-12-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-049422 | 16830 | ||||||
| 2021-11-08 | 4 | FORM 4 SUBMISSION | 0000899243-21-043520 | 5401 | ||||||
| 2021-11-08 | 3 | FORM 3 SUBMISSION | 0000899243-21-043518 | 6831 | ||||||
| 2021-11-08 | 10-Q | 10-Q | 0000950170-21-003317 | 001-39208 | 211386638 | 34 | 12628473 | 1 | 1 | |
| 2021-11-08 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-21-003291 | 001-39208 | 211386418 | 34 | 414443 | 1 | 1 |
| 2021-10-08 | 4 | FORM 4 SUBMISSION | 0000899243-21-039697 | 22548 | ||||||
| 2021-09-21 | 4 | FORM 4 SUBMISSION | 0000899243-21-036829 | 7086 | ||||||
| 2021-09-21 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-036823 | 9936 | ||||||
| 2021-09-21 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-036822 | 9911 | ||||||
| 2021-08-26 | 4 | PRIMARY DOCUMENT | 0000315066-21-001703 | 16832 | ||||||
| 2021-08-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-033848 | 18854 | ||||||
| 2021-08-16 | 4/A | PRIMARY DOCUMENT | 0000315066-21-001702 | 19943 | ||||||
| 2021-08-10 | 4 | PRIMARY DOCUMENT | 0000315066-21-001699 | 15116 | ||||||
| 2021-08-10 | 10-Q | 10-Q | 0000950170-21-001110 | 001-39208 | 211158448 | 34 | 11833672 | 1 | 1 | |
| 2021-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-001108 | 001-39208 | 211158373 | 34 | 385195 | 1 | 1 |
| 2021-07-08 | 4 | FORM 4 SUBMISSION | 0000899243-21-027902 | 28096 | ||||||
| 2021-07-08 | 4 | FORM 4 SUBMISSION | 0000899243-21-027903 | 31391 | ||||||
| 2021-07-07 | 424B5 | 424B5 | 0001193125-21-209882 | 333-254946 | 211077539 | 33 | 369188 | |||
| 2021-07-07 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-209865 | 001-39208 | 211077443 | 34 | 208646 | 1 | 1 |
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-027313 | 10426 | ||||||
| 2021-07-02 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-006294 | 9128 | ||||||
| 2021-07-02 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-006293 | 24247 | ||||||
| 2021-06-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-026782 | 16369 | ||||||
| 2021-06-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-026780 | 22124 | ||||||
| 2021-06-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-026781 | 8553 | ||||||
| 2021-06-30 | 4 | FORM 4 SUBMISSION | 0000899243-21-026779 | 20268 | ||||||
| 2021-06-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-006092 | 31750 | ||||||
| 2021-06-29 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-006091 | 13690 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0000899243-21-025510 | 001-40489 | 211038991 | 34 | 7216 | |||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0000899243-21-024327 | 001-40489 | 211023155 | 34 | 5080 | |||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0000899243-21-023471 | 5337 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0000899243-21-023469 | 5356 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0000899243-21-023467 | 5323 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0000899243-21-023465 | 5342 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0000899243-21-023464 | 5348 | ||||||
| 2021-06-11 | 8-K | 8-K | 5.07 | 0001564590-21-032654 | 001-39208 | 211011376 | 34 | 193844 | 1 | 1 |
| 2021-06-10 | SC 13G | SC 13G | 0001104659-21-079264 | 005-91369 | 211007580 | 34 | 45521 | |||
| 2021-06-10 | S-3ASR | S-3ASR | 0001193125-21-187286 | 333-256962 | 211006875 | 33 | 410378 | |||
| 2021-05-24 | 8-K | 8-K | 5.02 | 0001564590-21-029509 | 001-39208 | 21955008 | 34 | 162388 | 1 | 1 |
One latest value per concept from companyfacts (272 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 103.50M | 2026-10-27 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.70B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.58M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161512 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.31M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161512 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161512 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 8.40M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161512 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 5.82M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161512 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 33.95 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-17 | 0001193125-26-161512 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 20.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 40.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 4.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 110.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -3.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 2.95B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock | USD | 1.28M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions | APIC, Share-based Payment Arrangement, Recognition and Exercise | USD | 4.65M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 18.55M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 56.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 206,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 16.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | Assets | Assets | USD | 1.27B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.07B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 26,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 7,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 321.36M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 321.38M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 321.38M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 | |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | 2.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 1.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 5.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 1.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 620,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-020622 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 213.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 1.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 219.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -81.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 250.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 103.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 103.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -355.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 6.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 135.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ContributionOfProperty | Contribution of Property | USD | 25.50M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 303.33M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 29.13M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 3.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment | Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 1.82M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsDerivativeInstruments | Deferred Tax Assets, Derivative Instruments | USD | 2.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 484.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 141.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 58,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 100.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 26.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 7.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 455.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 27.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 267,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 2.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.06 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | Depreciation | Depreciation | USD | 16.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 16.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 16.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 4.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | DirectFinancingLeaseResidualValueOfLeasedAsset | Direct Financing Lease, Residual Value of Leased Asset | USD | 675,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -3.35 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.147 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.016 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | -0.038 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.131 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.07 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.127 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.047 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 18.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 79.40M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | EquityMethodInvestmentRealizedGainLossOnDisposal | Equity Method Investment, Realized Gain (Loss) on Disposal | USD | 455,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 | |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 3.60M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | EquitySecuritiesFvNiGainLoss | Equity Securities, FV-NI, Gain (Loss) | USD | -667,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 3.01M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 1.08M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-060683 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 304,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-060683 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 2.52M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 2.01M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 511,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 192,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -43,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 97.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | GuaranteeObligationsCurrentCarryingValue | Guarantor Obligations, Current Carrying Value | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | HeldToMaturitySecurities | Debt Securities, Held-to-maturity | USD | 406.26M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | USD | 14,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss | USD | 38,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Less than 12 Months, Fair Value | USD | 82.80M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue | Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | HeldToMaturitySecuritiesCurrent | Debt Securities, Held-to-maturity, Current | USD | 406.24M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions | Held-to-maturity, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security | 21 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | HeldtomaturitySecuritiesSoldSecurityRealizedGainLossExcludingOtherThanTemporaryImpairments | Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment | USD | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -79.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -376.70M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 255.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 159,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 11.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -16.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 20,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 3.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 10.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 10.17M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 5.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -15.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -6.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -10.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 197,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-020622 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 197,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 263,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 23.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 1.36M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-12 | 0001564590-20-039490 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 5.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 8.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | LeaseCost | Lease, Cost | USD | 32.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 210.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 91.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 24.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 21.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 22.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 25.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 25.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 4.69M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-07 | 0000950170-22-022322 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 56.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | Liabilities | Liabilities | USD | 316.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.27B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 82.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 100.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 100.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 24.54M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 20.20M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091242 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 830.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053939 |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 106.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 117.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -305.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -351.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -351.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Value of Liabilities Assumed | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 23.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 407.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -375.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 21.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 154.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 15.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 127.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 24.43M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 92.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 9.67M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.073 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 5.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 7.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -4.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -1.25M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 368,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -3,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | -1.19M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 4.50M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 813,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 631,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 444.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | PaymentsToAcquireEquitySecuritiesFvNi | PaymentsToAcquireEquitySecuritiesFvNi | USD | 750,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | PaymentsToAcquireHeldToMaturitySecurities | Payments to Acquire Held-to-maturity Securities | USD | 289.22M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | PaymentsToAcquireLongtermInvestments | Payments to Acquire Long-term Investments | USD | 750,000 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0000950170-21-003317 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 5.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 25.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 23.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 93.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 192.51M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 236.57M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 37.90M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002166 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 566.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities | Proceeds from Sale and Maturity of Held-to-maturity Securities | USD | 20.45M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ProceedsFromSaleOfEquityMethodInvestments | Proceeds from Sale of Equity Method Investments | USD | 455,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 10.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 2.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -351.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 204.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 94.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 302.05M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Expenses from Transactions with Related Party | USD | 5.50M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 309.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 154.95M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 6.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | RestructuringAndRelatedCostIncurredCost | Restructuring and Related Cost, Incurred Cost | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | Positions | 100 | 2023-10-01 | 2023-10-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.2 | 2023-10-01 | 2023-10-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 6.49M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 4.50M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026076 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.99B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 32.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | Revenues | Revenues | USD | 6,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.52M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053939 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 126.60M | 2020-10-01 | 2020-10-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 5.75M | 2020-10-01 | 2020-10-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 23.5 | 2020-10-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 | |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 28.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 56.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.809 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.797 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 42.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 8.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 39.19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 3.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 583,603 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 20.2 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 53.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 12.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 34.92 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 15.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 42.69 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 28.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 4.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 952.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 4.484 | 2020-01-01 | 2020-01-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 |
| us-gaap | StockIssued1 | Stock Issued | USD | 5.75M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 686,283 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 6.71M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 303.33M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 1.37M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 34.94M | 2023-07-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-060683 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 959,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 487,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 1.28M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-28 | 0000950170-23-004866 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 302.05M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 282.02M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 130.67M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-15 | 0001564590-21-013190 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 17.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 6.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001193125-26-065194 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 104.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 60.21M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-11 | 0001564590-21-026555 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 104.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-444455 |